Original Source(s)
Related Content
FDA approves first therapy for warm autoimmune hemolytic anemia
The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.
August 25, 2026
-
3 min
Are law enforcement death rates rising?
Death-certificate data showed increases among adults and children over 2 decades, with Black males consistently recording the highest rates.
August 19, 2026
-
4 min